Cargando…

Drug Resistance in Hematological Malignancies

Detalles Bibliográficos
Autores principales: Auberger, Patrick, Tamburini-Bonnefoy, Jerome, Puissant, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503602/
https://www.ncbi.nlm.nih.gov/pubmed/32847013
http://dx.doi.org/10.3390/ijms21176091
_version_ 1783584432122232832
author Auberger, Patrick
Tamburini-Bonnefoy, Jerome
Puissant, Alexandre
author_facet Auberger, Patrick
Tamburini-Bonnefoy, Jerome
Puissant, Alexandre
author_sort Auberger, Patrick
collection PubMed
description
format Online
Article
Text
id pubmed-7503602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75036022020-09-27 Drug Resistance in Hematological Malignancies Auberger, Patrick Tamburini-Bonnefoy, Jerome Puissant, Alexandre Int J Mol Sci Editorial MDPI 2020-08-24 /pmc/articles/PMC7503602/ /pubmed/32847013 http://dx.doi.org/10.3390/ijms21176091 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Auberger, Patrick
Tamburini-Bonnefoy, Jerome
Puissant, Alexandre
Drug Resistance in Hematological Malignancies
title Drug Resistance in Hematological Malignancies
title_full Drug Resistance in Hematological Malignancies
title_fullStr Drug Resistance in Hematological Malignancies
title_full_unstemmed Drug Resistance in Hematological Malignancies
title_short Drug Resistance in Hematological Malignancies
title_sort drug resistance in hematological malignancies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503602/
https://www.ncbi.nlm.nih.gov/pubmed/32847013
http://dx.doi.org/10.3390/ijms21176091
work_keys_str_mv AT aubergerpatrick drugresistanceinhematologicalmalignancies
AT tamburinibonnefoyjerome drugresistanceinhematologicalmalignancies
AT puissantalexandre drugresistanceinhematologicalmalignancies